Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.

@article{Rasmussen1989InfluenceOM,
  title={Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.},
  author={Hans Morten Schnack Rasmussen and Peter Aurup and Karen Goldstein and Peter McNair and Per Brobech Mortensen and Oystein Gran Larsen and Henrik Lawaetz},
  journal={Archives of internal medicine},
  year={1989},
  volume={149 5},
  pages={1050-3}
}
In a double-blind, placebo-controlled study, 47 patients with ischemic heart disease and acute myocardial infarction were allocated to 3 months' treatment with peroral magnesium (15 mmol/d) or placebo. Before, during, and after treatment, blood samples were taken to determine serum concentrations of cholesterol; triglyceride; high-density, low-density, and very-low-density lipoprotein; apolipoprotein A1 and B; and magnesium. We found a 13% increase in molar ratio of apolipoprotein A1… CONTINUE READING